Rejection of Mouse Renal Cell Carcinoma Elicited by Local Secretion of Interleukin-2-Reference-Cited by-同舟云学术

Rejection of Mouse Renal Cell Carcinoma Elicited by Local Secretion of Interleukin-2

Published:1996-07 Issue:7 Volume:87 Page:724-729
ISSN:0910-5050
Container-title:Japanese Journal of Cancer Research
language:en
Short-container-title:

Author:

Hara Isao,Hotta Hak,Sato Noriyuki,Eto Hiroshi,Arakawa Soichi,Kamidono Sadao

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.1996.tb00284.x/fullpdf

Reference21 articles.

1. Cancer immunotherapy using interleukin-2 and interleukin-2-activated lymphocytes;Rosenberg;Annu. Rev. Immunol,1986

2. Interleukin 2 is both necessary and sufficient for the growth and differentiation of lectin-stimulated cytolytic T lymphocyte precursors;Erard;J. Immunol,1985

3. Cardiorespiratory effects of immunotherapy with interleukin-2;Lee;J. Clin. Oncol,1989

4. Rejection of mouse melanoma elicited by local secretion of interleukin-2: implication of macrophages without T cells or natural killer cells in tumor rejection;Hara;Int. J. Cancer,1995

5. Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response;Fearon;Cell,1990

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the dynamics of a tumor-immune interplay with time delay;Alexandria Engineering Journal;2021-10

2. Employing dynamical computational models for personalizing cancer immunotherapy;Expert Opinion on Biological Therapy;2016-08-26

3. Optimal control of mixed immunotherapy and chemotherapy of tumours with discrete delay;International Journal of Dynamics and Control;2015-12-16

4. The combined effects of optimal control in cancer remission;Applied Mathematics and Computation;2015-11

5. IL-23 gene therapy for mouse bladder tumour cell lines;BJU International;2011-03-24